Form 4: 4D Molecular Therapeutics Chief Legal Officer Exercises Stock Options and Sells Shares
SEC Form 4
Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.
Summary
- On April 1, 2024, Scott Bizily, the Chief Legal Officer of 4D Molecular Therapeutics, exercised stock options to acquire common stock at prices of $6.49, $8.04, $15.78, and $20.24.
- He then sold 8,153 shares of common stock at a price of $31.78.
- These transactions were executed under a pre-arranged 10b5-1 trading plan adopted on October 10, 2023.
- Following these transactions, Bizily directly owns 1,737 shares of common stock and holds options to purchase a total of 122,319 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions by an officer. The existence of a 10b5-1 plan suggests pre-planned and orderly transactions.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased transparency regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 2022-03-01 | Vesting Commencement Date for some stock options. |
| 2022-06-16 | Vesting Commencement Date for some stock options. |
| 2022-09-01 | Vesting Commencement Date for some stock options. |
| 2023-02-10 | Vesting Commencement Date for some stock options. |
| 2023-10-10 | Date the 10b5-1 trading plan was adopted. |
| 2024-04-01 | Date of the stock option exercise and share sale. |
| 2032-01-31 | Expiration date for some stock options. |
| 2032-06-17 | Expiration date for some stock options. |
| 2032-08-31 | Expiration date for some stock options. |
| 2033-02-09 | Expiration date for some stock options. |
| 2024-04-03 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.